Drábek J
LEM, Faculty of Medicine, Palacký University, Puskinova 6, 77520 Olomouc, Czech Republic.
Forensic Sci Int Genet. 2009 Mar;3(2):112-8. doi: 10.1016/j.fsigen.2008.11.005. Epub 2008 Dec 24.
Although the likelihood ratio is a well-known statistical technique, commercial off-the-shelf (COTS) software products for its calculation are not sufficiently validated to suit general requirements for the competence of testing and calibration laboratories (EN/ISO/IEC 17025:2005 norm) per se. The software in question can be considered critical as it directly weighs the forensic evidence allowing judges to decide on guilt or innocence or to identify person or kin (i.e.: in mass fatalities). For these reasons, accredited laboratories shall validate likelihood ratio software in accordance with the above norm. To validate software for calculating the likelihood ratio in parentage/kinship scenarios I assessed available vendors, chose two programs (Paternity Index and familias) for testing, and finally validated them using tests derived from elaboration of the available guidelines for the field of forensics, biomedicine, and software engineering. MS Excel calculation using known likelihood ratio formulas or peer-reviewed results of difficult paternity cases were used as a reference. Using seven testing cases, it was found that both programs satisfied the requirements for basic paternity cases. However, only a combination of two software programs fulfills the criteria needed for our purpose in the whole spectrum of functions under validation with the exceptions of providing algebraic formulas in cases of mutation and/or silent allele.
尽管似然比是一种广为人知的统计技术,但用于计算似然比的商业现货(COTS)软件产品本身并未得到充分验证,无法满足测试和校准实验室能力的一般要求(EN/ISO/IEC 17025:2005标准)。所讨论的软件可被视为关键软件,因为它直接权衡法医证据,使法官能够判定有罪或无罪,或识别个人或亲属(即:在大规模死亡事件中)。出于这些原因,认可实验室应根据上述标准对似然比软件进行验证。为了验证用于亲子关系/亲属关系场景中计算似然比的软件,我评估了现有的供应商,选择了两个程序(父权指数和familias)进行测试,最后使用从法医学、生物医学和软件工程领域的现有指南中提炼出的测试方法对它们进行了验证。使用已知似然比公式的MS Excel计算或疑难亲子鉴定案例的同行评审结果作为参考。通过七个测试案例发现,这两个程序都满足基本亲子鉴定案例的要求。然而,在验证的整个功能范围内,只有两个软件程序的组合满足我们的目的所需的标准,但在突变和/或沉默等位基因情况下提供代数公式的情况除外。